Laser versus conventional treatment for active acne in primary care
| ISRCTN | ISRCTN78675673 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN78675673 |
| Protocol serial number | N/A |
| Sponsor | West London Research Network (WeLReN) (UK) |
| Funder | West London Research Network (WeLReN) (UK) |
- Submission date
- 25/02/2005
- Registration date
- 10/05/2005
- Last edited
- 10/11/2022
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Colin Lyons
Scientific
Scientific
68 Engadine Street
London
SW18 5DA
United Kingdom
| Phone | +44 (0)7810 39 1917 |
|---|---|
| colin.Lyons@gp-e85003.nhs.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | Laser versus conventional treatment for active acne in primary care: a randomised ocntrolled trial |
| Study objectives | The study compares laser treatment (pulsed dye laser at 585 nm; N-Lite® to 'best conventional treatment' for inflammatory active acne in primary care. The hypothesis is that laser works better, faster and cheaper. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Acne vulgaris |
| Intervention | 1. Pulsed-dye laser at 585 nm 2. Lymecycline orally & isotretinoin gel topically |
| Intervention type | Drug |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Lymecycline orally & isotretinoin gel topically |
| Primary outcome measure(s) |
Improvement after 3 months in both groups using the Leeds revised grading system |
| Key secondary outcome measure(s) |
Patient satisfaction, compliance, cost |
| Completion date | 31/10/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 40 |
| Key inclusion criteria | Age 16-45 with moderate active inflammatory acne vulgaris |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/02/2005 |
| Date of final enrolment | 31/10/2005 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
68 Engadine Street
London
SW18 5DA
United Kingdom
SW18 5DA
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan | Not provided at time of registration |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Other publications | Outcome measures in acne vulgaris: systematic review | 01/01/2009 | Yes | No |
Editorial Notes
10/11/2022: Proactive update review. No publications found. Search options exhausted.
